Although exposure to ultraviolet rays is a primary cause of skin cancer, factors such as your age, sex, and smoking habits also may contribute to developing this health issue.

How Interdisciplinary Care Helped a Dental Patient Recover from Mouth Cancer ...

Regeneron Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its blockbuster cancer drug Libtayo for certain ...

A phase 2 trial evaluated the combination of neoadjuvant pembrolizumab and accelerated methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in patients with nonurothelial bladder cancers ...

A new deep learning tool accurately predicts metastatic risk in cSCC, outperforming current clinicopathological and molecular ...

The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...

Could a daily vitamin B3 pill prevent skin cancer? New research finds nicotinamide cuts recurrence risk by more than half in ...

The company is studying the mRNA tumor-associated antigen vaccine as a monotherapy and in combination with Keytruda.

Diane Keaton's death at age 79 sent shockwaves through Hollywood, but the actress had multiple health battles prior to her ...

A new study published in Current Molecular Pharmacology identifies the DKK1:CALML5 ratio as a potential biomarker for ...

Libtayo gained FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, promising improved ...

Libtayo's FDA approval offers an effective adjuvant option for high-risk cutaneous squamous cell carcinoma, reducing ...